Clin2
NCT06601452Possibly a fitEnrolling by invitation

Chinese medicine for anovulatory infertility in IVF

Polycystic Ovary SyndromeDiminished Ovarian ReserveOvulation Disorder

Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.

This trial tests a treatment for women with infertility caused by ovulation problems, like PCOS or low ovarian reserve, or when IVF is needed due to a male factor. It aims to see if a Chinese medicine approach can help improve IVF success.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
650 people
Ages
20 years to 41 years
Study type
Interventional

Who can take part

  • You are between 28 and 34 years old.
  • You have been diagnosed with PCOS (polycystic ovary syndrome) or DOR (diminished ovarian reserve), or you are doing IVF because of a male factor.
  • Your body mass index (BMI) is under 25.
  • You do not have uterine issues like polyps, fibroids, endometriosis, or a history of repeated miscarriages.
  • You have not used any hormone-affecting medications in the last 3 months.
  • You are willing to use an IVF antagonist or microstimulation protocol and can tolerate the treatment.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07535983Recruiting· Phase 1/Phase 2
Chinese herbal medicine plus DHEA for low egg reserve

This trial tests whether a traditional Chinese medicine decoction combined with DHEA (a supplement) can improve ovarian function in women with diminished ovarian reserve—a condition where the ovaries produce fewer healthy eggs. The study combines two treatment approaches to see if they work better together.

Nanchang, Jiangxi
NCT06794047Recruiting
Vitamin C for IVF in women with low ovarian reserve

This study tests whether taking Vitamin C can improve IVF outcomes for women with low ovarian reserve (DOR). If you are starting your first or second IVF cycle and meet certain health criteria, you may be eligible.

Beijing, Beijing Municipality
NCT04149496Recruiting
IVF cycle study using modified egg-retrieval timing

This study tests an IVF approach that changes how ovarian stimulation is started, helps retrieve eggs more effectively, and may delay embryo transfer. It may help people who have many small eggs (called antral follicles) and higher AMH levels, which can affect how IVF works.

Jacksonville, Florida
NCT07296614Not yet recruiting· Phase 3
Combined Chinese and Western medicine for natural pregnancy in women with low egg supply

This study tests a combination of Western medicine and traditional Chinese medicine to help women with low egg supply (diminished ovarian reserve) get pregnant naturally. If you qualify, you may receive a treatment that could improve your chances of conceiving.

Beijing, Beijing Municipality
NCT07347340Not yet recruiting· Phase 3
Herbal pretreatment for IVF success in women with low egg reserve

This study tests whether taking a Chinese herbal formula before and during an IVF cycle improves the chance of pregnancy in women with low egg reserve. It compares the herbal pretreatment to no herbal treatment to see if it helps more women get pregnant.

Beijing, Beijing Municipality
NCT07550998Recruiting· Phase 3
Yulinzhu herbal treatment for low egg reserve

This trial tests whether a traditional Chinese herbal medicine called Yulinzhu can help women with diminished ovarian reserve (low egg count or quality) improve their chances of pregnancy. The study includes 12 weeks of treatment followed by IVF if you don't conceive naturally.

Hong Kong

Hear when a new Polycystic Ovary Syndrome trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.